2841 Picrotoxin Picrotoxin is an exogenous solid with the chemical formula C30H34O13. Picrotoxin belongs to the furopyrans, a class of organoheterocyclic compounds within the organic compounds. With an average molecular weight of 602.58 g/mol, Picrotoxin is a heavy molecule. This compound acts as a noncompetitive antagonist at GABA-A receptors and serves as a convulsant. It blocks the gamma-aminobutyric acid-activated chloride ionophore. Picrotoxin antagonizes the GABAA receptor channel directly, which is a ligand-gated ion channel concerned chiefly with the passing of chloride ions across the cell membrane; consequently, it prevents Cl- channel permeability and promotes an inhibitory influence on the target neuron. It reduces conductance through the channel by reducing the mean open time and the opening frequency. Additionally, picrotoxin antagonizes GABAC receptors (also called GABAA-rho receptors). Recorded protein targets include GABRA1, GABRR1, GLRA1, GLRA2, and GLRA3. While primarily used as a research tool, it has been used as an antidote in poisoning by CNS depressants, especially barbiturates, and as a CNS stimulant. 124-87-8 31304 C30H34O13 602.199940 White powder. 203.5°C 4100 mg/L Oral Picrotoxin antagonizes the GABA_A receptor channel directly, which is a ligand-gated ion channel concerned chiefly with the passing of chloride ions across the cell membrane. Therefore picrotoxin prevents Cl^- channel permeability and thus promtes an inhibitory influence on the target neuron. Picrotoxin reduces conductance through the channel by reducing not only the opening frequency but also the mean open time. Picrotoxin also antagonizes GABA_C receptors (also called GABA_A-rho receptors) but the result of this action is not known. The GABA_C receptor is also linked to chloride channels, with distinct physiological and pharmacological properties. In contrast to the fast and transient responses elicited from GABA_A receptors, GABA_C receptors mediate slow and sustained responses. LD50: 15 mg/kg (Oral, mouse) No indication of carcinogenicity to humans (not listed by IARC). Used internally for relieving respiratory distress. Also for use as an antidote in poisoning by CNS depressants, especially barbiturates. Using large amounts of these drugs can result in a condition known as amphetamine psychosis -- which can result in auditory, visual and tactile hallucinations, intense paranoia, irrational thoughts and beliefs, delusions, and mental confusion. Using large amounts of these drugs can result in a condition known as amphetamine psychosis -- which can result in auditory, visual and tactile hallucinations, intense paranoia, irrational thoughts and beliefs, delusions, and mental confusion. In large doses it is a powerful poison, causing unconsciousness, delirium, convulsions, gastro-enteritis and stimulation of the respiratory centre followed by paralysis, from which death sometimes results. 2009-07-21T20:26:57Z 2026-05-14T16:39:40Z Picrotoxin C09529 Picrotoxin DB00466 true [H][C@@]12OC(=O)[C@@]34OC3C[C@@](O)(C3[C@@H](C1OC3=O)C(C)=C)[C@@]24C.[H][C@@]12C[C@@]3(O)C4[C@@H](C(OC4=O)[C@@]4([H])OC(=O)[C@]1(O2)[C@@]34C)C(C)(C)O C30H34O13 InChI=1S/C15H18O7.C15H16O6/c1-12(2,18)6-7-10(16)20-8(6)9-13(3)14(7,19)4-5-15(13,22-5)11(17)21-9;1-5(2)7-8-11(16)19-9(7)10-13(3)14(8,18)4-6-15(13,21-6)12(17)20-10/h5-9,18-19H,4H2,1-3H3;6-10,18H,1,4H2,2-3H3/t5-,6+,7?,8?,9-,13-,14-,15+;6?,7-,8?,9?,10+,13+,14+,15-/m10/s1 VJKUPQSHOVKBCO-ZTYBEOBUSA-N 602.5832 602.199941174 Exogenous Solid -2.229 HMDB14609 CHEMBL1908342 29044 CHEM002201 DTXSID7045605 NS00041393 (1R,3R,5S,8S,13R,14S)-1-hydroxy-14-(2-hydroxypropan-2-yl)-13-methyl-4,7,10-trioxapentacyclo[6.4.1.1^{9,12}.0^{3,5}.0^{5,13}]tetradecane-6,11-dione; (1R,5S,8S,13R,14R)-1-hydroxy-13-methyl-14-(prop-1-en-2-yl)-4,7,10-trioxapentacyclo[6.4.1.1^{9,12}.0^{3,5}.0^{5,13}]tetradecane-6,11-dione 105.59 68.2899 28.53476726117275 2 5 2 13.596322447809218 -2.822292376099419 0 10 Organic compounds Organoheterocyclic compounds Furopyrans 6328 CED0002610 VJKUPQSHOVKBCO-ZTYBEOBUSA-N 8000000000000000000400000200000000020000000020000000400000000000000000000002000090000000000400080000000000000000010000000400000000000000000000000000000000000002080004120000020000000000a0000000000001100000000000000000000000000000200040000000000000008005200000000c8020000000000000001000022000406000000000000000000000020000000000000002000000200080000000000000000000000000000010000000000000000000000000800000040000000000000002000000020000000000000000000100000000000000000000048080000000000000000000000000000000000 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 776t3gAAAAAQAAAAAwAAAAAAAAArAAAAMwAAAIABBiA0AAAAAgEECAAoAAAA AwIGACgAAAADBAgAKAAAAAMCBiAkAAAAAQQIACAAAAACBgBgAAAAAwEGAGAA AAACAgYgJAAAAAEECABgAAAAAQEGAGAAAAADAQYgNAAAAAEBBAYAYAAAAAMB CAAoAAAAAwIGACgAAAADBAgAKAAAAAMCBgAoAAAAAwQGAGAAAAABAwYAaAAA AAMCAgYgJAAAAAEEBgBgAAAAAQMGIDQAAAACAQQGAGAAAAACAgYgJAAAAAEE CABgAAAAAQEGAGAAAAADAQYgNAAAAAEBBAYAYAAAAAMBCAAoAAAAAwIGACgA AAADBAgAKAAAAAMCBiA0AAAAAQEECAAoAAAAAwIGACgAAAADBAgAKAAAAAMC BiAkAAAAAgQIACAAAAACBiAkAAAAAQQGAGAAAAABAwYAIAAAAAQGAGAAAAAB AwYAYAAAAAEDCABgAAAAAQELAAEAAQIgAgMoAgIEAAQFAAUGAAYHAAcIAAgJ AAgKAAoLAAsMAAwNAA0OIA4PKAILEAAQEQAQEggCCBMAExQAFRYAFhcAFxgA FxkAGRoAGhsAGxwAHB0gHR4oAhsfAB8gACAhICEiKAIhIwAjJAAjJQAlJgAa JwAnKAAnKQAnKgAMAAAjFQATAAAkFQAGBAAOCgAlFwATBAAdGQAlHwBCCgAA AAUBABMEAgMFBAYFBwYEEwgFCwoODQwGCwwAEwgKBRYVIyUXBRoZHRwbBSAf JSMhAyQjFQYaGx8lFxkXBAAAAAAAAAAW 2026-09-19T04:00:34Z